Case number 1:17-cv-01155
Onyx Therapeutics, Inc. v. InnoPharma Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 8, 2019 | 13 | Order (3) Docket Text: CONSENT JUDGMENT re InnoPharma, ***Civil Case Terminated. Signed by Judge Leonard P. Stark on 5/7/19. Associated Cases: 1:16-cv-01036-LPS, 1:17-cv-01155-LPS (ntl) |
| May 3, 2019 | 12 | Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT by InnoPharma Inc.. (Phillips, John) |
| Dec 20, 2018 | 11 | Redacted Document (30) Docket Text: REDACTED VERSION of (322 in 1:16-cv-00988-LPS, 322 in 1:16-cv-00988-LPS) Answer to Complaint, Counterclaim, (10 in 1:17-cv-01155-LPS, 10 in 1:17-cv-01155-LPS) Answer to Complaint, Counterclaim by InnoPharma Inc.. (Phillips, John) |
| Sep 14, 2017 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (9 in 1:17-cv-01202-LPS, 9 in 1:17-cv-01155-LPS, 8 in 1:17-cv-01235-LPS) Stipulation and Order to Consolidate with lead case no. 16-988-LPS. ALL FILINGS SHALL BE MADE IN LEAD CASE NO. 16-988-LPS. Signed by Judge Leonard P. Stark on 9/14/17. Associated Cases: 1:17-cv-01155-LPS, 1:17-cv-01202-LPS, 1:17-cv-01235-LPS (ntl) |
| Sep 14, 2017 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:16-cv-00988-LPS. (ntl) |
| Sep 13, 2017 | 9 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Consolidate by InnoPharma Inc.. (Bilson, David) |
| Sep 8, 2017 | 7 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against Onyx Therapeutics, Inc. by InnoPharma Inc..(Phillips, John) |
| Sep 8, 2017 | 8 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for InnoPharma Inc. filed by InnoPharma Inc.. (Phillips, John) |
| Aug 23, 2017 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Aug 18, 2017 | 6 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Onyx Therapeutics, Inc.. InnoPharma Inc. served on 8/18/2017, answer due 9/8/2017. (Blumenfeld, Jack) |
| Aug 17, 2017 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to InnoPharma Inc. on 8/17/2017. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sar) |
| Aug 17, 2017 | 1 | Complaint (21) |
| Aug 17, 2017 | 1 | Exhibit A-F (236) |
| Aug 17, 2017 | 1 | Civil Cover Sheet (2) |
| Aug 17, 2017 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) |
| Aug 17, 2017 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 7/7/17. Date of Expiration of Patent: *SEE LIST*Thirty Month Stay Deadline: 1/20/2020. (sar) |
| Aug 17, 2017 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,232,818 B2; 7,491,704 B2; 8,129,346 B2; 8,207,125 B2; 8,207,126 B2. (sar) |
| Aug 17, 2017 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amgen Inc., Corporate Parent Onyx Pharmaceuticals, Inc. for Onyx Therapeutics, Inc. filed by Onyx Therapeutics, Inc.. (sar) |
| Aug 17, 2017 | 1 | Main Document (21) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against InnoPharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2205452.) - filed by Onyx Therapeutics, Inc.. (Attachments: # (1) Exhibit A-F, # (2) Civil Cover Sheet)(sar) |
| Aug 17, 2017 | 1 | Complaint* (1) |
